MedTrace Logo

PET-CT and Circulating Tumor Cells in Colorectal Cancer

NCT01163305 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 84

Last updated 2017-05-08

No results posted yet for this study

Summary

The purpose of this study is to identify an early indicator of drug efficacy in patients with advanced colorectal cancer - a prospective evaluation of circulating tumor cells, positron-emission tomography scan and RECIST criteria.

Conditions

Interventions

DRUG

Chemotherapy

The majority of patients offered either oxaliplatin or irinotecan-based chemotherapy

Sponsors & Collaborators

  • Chinese University of Hong Kong

    lead OTHER

Principal Investigators

  • Brigette Ma, MD, FRCP · Department of Clinical Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2017-04-27
Completion
2017-04-27

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01163305 on ClinicalTrials.gov